Tumour necrosis factor as an anticancer agent.
Balkwill
F R
FR
Biological Therapy Laboratory, Imperial Cancer Research Fund, London, U.K.
Naylor
M S
MS
Malik
S
S
D000818:Animals; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha